Management of Immunosuppression in Kidney Transplant Recipients with Recurrent UTI-Related Fever

Assessment and Management Approach

• The Infectious Diseases Society of America recommends confirming the diagnosis with urine culture and sensitivity testing to guide appropriate antibiotic therapy 1
• The assessment of infection severity, such as simple UTI vs. pyelonephritis, is crucial as it impacts management decisions 2
• For allograft pyelonephritis, initial hospitalization and treatment with intravenous antibiotics is suggested, as recommended by the Kidney International guidelines 3

Immunosuppression Management During Active UTI

• For severe or life-threatening UTI with fever, temporarily reducing immunosuppressive medication until the infection resolves is recommended by the Clinical Infectious Diseases guidelines 1, 2
• The Kidney International guidelines suggest reducing or temporarily holding antimetabolites, such as azathioprine, as a first step in immunosuppression reduction 4
• The Clinical Infectious Diseases guidelines recommend reducing calcineurin inhibitor dose by 25-50% while monitoring levels closely 5
• Maintaining baseline corticosteroids to prevent adrenal insufficiency is recommended by the Clinical Infectious Diseases guidelines 2

Antimicrobial Management

• The Kidney International guidelines recommend treating recurrent UTIs with prophylactic antibiotics, such as trimethoprim-sulfamethoxazole, if not already on it 3
• Ensuring that the patient has completed at least 6 months of post-transplant UTI prophylaxis with trimethoprim-sulfamethoxazole is recommended by the Kidney International guidelines 3

Special Considerations

• The risk of rejection with immunosuppression reduction is lower in patients who are more than 1 month post-transplant, as stated by the Clinical Infectious Diseases guidelines 2
• The IDSA guidelines specifically recommend against screening for or treating asymptomatic bacteriuria in renal transplant recipients who are more than 1 month post-transplant 1, 2

Monitoring During Immunosuppression Adjustment

• Monitoring graft function closely during the UTI and after any adjustment in immunosuppression is recommended by the Kidney International guidelines 4
• Following creatinine levels and estimated GFR to detect early signs of rejection is recommended by the Clinical Infectious Diseases guidelines 2
• Resuming full immunosuppression once the infection is controlled and fever resolves is recommended by the Clinical Infectious Diseases guidelines 5

Potential Pitfalls and Caveats

• Excessive reduction in immunosuppression may trigger rejection, while inadequate reduction may allow persistence of infection, as stated by the Clinical Infectious Diseases guidelines 2
• Certain antibiotics, such as macrolides and some antifungals, can significantly increase calcineurin inhibitor levels, as reported by the Kidney International guidelines 4